Catalent Inc CTLT:NYSE

RT Quote | NYSE | USD
Last | 09/26/22 EDT
74.73quote price arrow down-1.34 (-1.76%)
Volume
2,038,593
52 week range
74.73 - 141.34
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close74.73
  • 52 Week High141.34
  • 52 Week High Date09/27/21
  • 52 Week Low74.73
  • 52 Week Low Date09/26/22

Key Stats

  • Market Cap13.444B
  • Shares Out179.90M
  • 10 Day Average Volume1.54M
  • Dividend-
  • Dividend Yield-
  • Beta1.39
  • YTD % Change-41.63

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close74.73
  • 52 Week High141.34
  • 52 Week High Date09/27/21
  • 52 Week Low74.73
  • 52 Week Low Date09/26/22
  • Market Cap13.444B
  • Shares Out179.90M
  • 10 Day Average Volume1.54M
  • Dividend-
  • Dividend Yield-
  • Beta1.39
  • YTD % Change-41.63

RATIOS/PROFITABILITY

  • EPS (TTM)2.83
  • P/E (TTM)26.43
  • Fwd P/E (NTM)20.78
  • EBITDA (TTM)1.174B
  • ROE (TTM)11.60%
  • Revenue (TTM)4.828B
  • Gross Margin (TTM)33.97%
  • Net Margin (TTM)10.75%
  • Debt To Equity (MRQ)87.63%

EVENTS

  • Earnings Date10/31/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

Here's who could benefit from Biden's biotech initiative, according to Oppenheimer's Jared Holz
VIDEO4:5204:52
Here's who could benefit from Biden's biotech initiative, according to Oppenheimer's Jared Holz

Profile

MORE
Catalent, Inc. is a provider of development and manufacturing solutions for drug, cell and gene therapies biologics, vaccines, and consumer health products. The Company’s segments include Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. Its Biologics segment provides development and manufacturing for protein, plasmid DNA mRNA, cell therapy, viral vaccines and viral-based gene therapies. Its Softgel and Oral Technologies...
John Chiminski
Executive Chairman of the Board
Alessandro Maselli
President, Chief Executive Officer, Director
Thomas Castellano
Chief Financial Officer, Senior Vice President
Steven Fasman
Executive Vice President, Chief Administrative Officer, Interim General Counsel
Address
14 Schoolhouse Rd
Somerset, NJ
08873-1213
United States

Top Peers

SYMBOLLASTCHG%CHG
HZNP
Horizon Therapeutics PLC
61.79-1.18-1.87%
ELAN
Elanco Animal Health Inc
12.66-0.56-4.24%
BMRN
Biomarin Pharmaceutical Inc
82.16-2.68-3.16%
PRGO
Perrigo Company PLC
37.66-0.43-1.13%
RDY
Dr Reddy's Laboratories Ltd
49.90-0.75-1.48%